Martha Genig
Internal Medicine · Allen Park, MINPI 1902009822
Payments from drug & device makers
Across 140 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$429
- Lilly USA, LLC$429
- Johnson & Johnson$250
- Novartis$207
- Astellas Pharma US Inc$194
- Idorsia Pharmaceuticals US Inc$139
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,815100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 19 | $429 |
| Lilly USA, LLC | 22 | $429 |
| Johnson & Johnson | 12 | $250 |
| Novartis | 10 | $207 |
| Astellas Pharma US Inc | 10 | $194 |
| Idorsia Pharmaceuticals US Inc | 2 | $139 |
| Pfizer | 7 | $122 |
| Amgen(2 entities) | 7 | $118 |
| Bayer | 5 | $115 |
| Novo Nordisk | 6 | $103 |
| Amneal Pharmaceuticals LLC | 4 | $92 |
| AbbVie | 5 | $91 |
| Exact Sciences | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Acadia Pharmaceuticals Inc | 2 | $44 |
| AstraZeneca | 3 | $43 |
| GSK | 3 | $43 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Lundbeck LLC | 2 | $35 |
| Merck | 2 | $30 |
| Eisai Inc. | 2 | $27 |
| Alkermes, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $23 |
| Urovant Sciences Inc | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $17 |
| Inari Medical, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Biogen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,815 in reported general payments places this provider in the 85th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 23 | $40,360 |
| EliquisApixaban | 22 | $22,389 |
| JanuviaSitagliptin Phosphate | 14 | $22,132 |
| TrulicityDulaglutide | 13 | $19,484 |
| OzempicSemaglutide | 11 | $17,605 |
| XareltoRivaroxaban | 14 | $10,560 |
| InvokanaCanagliflozin | 11 | $6,320 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $2,604 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 78 | $2,357 |
| Atorvastatin Calcium | 147 | $1,877 |
| Levothyroxine Sodium | 89 | $1,115 |
| Omeprazole | 54 | $926 |
| Gabapentin | 76 | $908 |
| FenofibrateFenofibrate Nanocrystallized | 29 | $838 |
| Lisinopril | 113 | $726 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $429 | $59,84436 claims |
| PfizerEliquis | $122 | $22,38922 claims |
| MerckJanuvia | $30 | $22,13214 claims |
| Novo NordiskOzempic | $103 | $17,60511 claims |
| Johnson & JohnsonXarelto, Invokana | $250 | $16,88025 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $92 | $1,11589 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Allen Park
- Ulka VaishampayanAnn Arbor$33.7M
- Jeffrey PottsBay City$14.7M
- Neil FraserTroy$14.3M
- Abdulhassan SaadDearborn$11.5M
- Leslie PelkeyGrand Rapids$8.5M
- Jay SandbergTroy$8.3M
- Ding WangDetroit$6.8M
- Dipenkumar ModiDetroit$4.1M
- Ahmed ArifFlint$4.1M
- Sudipto MukherjeeRoyal Oak$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.